IRLAB Therapeutics AB (IRLAB A) NPV A

Sell:1.51 SEKBuy:1.52 SEKPrice decreased0.01 SEK (0.91%)

Prices delayed by at least 15 minutes
Sell:1.51 SEK
Buy:1.52 SEK
Change:Price decreased0.01 SEK (0.91%)
Deal now
Prices delayed by at least 15 minutes
Sell:1.51 SEK
Buy:1.52 SEK
Change:Price decreased0.01 SEK (0.91%)
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open1.54 SEK
Previous close1.54 SEK
Market capSEK 130.51m
P/E ratio-99999.99
Volume249,544
Dividend yield0.00%
EMS-

Company information

IRLAB Therapeutics AB is a Sweden-based research and development company. It focuses on illnesses in the central nervous system and primarily on development of drugs to assist patients with Parkinson’s disease. The ...

  • LocationSweden
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencySEK
  • Shares in issue84.86m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Balance sheet 2025

Total assetsSEK 138.21m
Total liabilitiesSEK 107.49m
Net debt-SEK 78.32m

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.